John Gordon
Interventional Cardiology · San Diego, CANPI 1962483099
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 250 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by Abbott at 31.9% of the total. Reporting peaked in 2019 at $3,021 and has fallen 94.0% since, to $180 in 2025. That places this record below the midpoint for interventional cardiology clinicians in CA, where the typical reported total is $8,581.
Across 250 payments — averaging $38.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- W. L. Gore & Associates, Inc.$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
- Amgen$622
- Shockwave Medical, Inc$480
- Medtronic$450
- plus $3K from 29 others
Across 14 payments — averaging $2239.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$31K
What the payments were for
- Food & beverage$9,602100%
- Education$220%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 47 | $3,067 |
| W. L. Gore & Associates, Inc. | 18 | $1,114 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 65 | $1,092 |
| Amgen | 11 | $622 |
| Shockwave Medical, Inc | 4 | $480 |
| Medtronic(2 entities) | 6 | $450 |
| Boston Scientific | 11 | $317 |
| Johnson & Johnson | 14 | $313 |
| Cathworks, Inc. | 4 | $293 |
| Novartis | 19 | $279 |
| Cvrx, Inc. | 4 | $196 |
| E.r. Squibb & Sons, L.L.C. | 5 | $161 |
| Esperion Therapeutics, Inc. | 3 | $158 |
| Philips North America LLC | 1 | $123 |
| Terumo Medical Corporation | 2 | $115 |
| Bayer | 2 | $114 |
| Heartflow, Inc. | 3 | $113 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $101 |
| AstraZeneca | 5 | $64 |
| GE HealthCare | 1 | $60 |
| Alnylam Pharmaceuticals Inc. | 3 | $49 |
| Baxter Healthcare | 1 | $47 |
| Pfizer | 2 | $35 |
| CSL Behring | 1 | $30 |
| Bardy Diagnostics, Inc. | 2 | $27 |
| Akcea Therapeutics, Inc. | 1 | $26 |
| Irhythm Technologies, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $23 |
| Tactile Systems Technology Inc | 2 | $23 |
| Biosense Webster, Inc. | 1 | $23 |
| Biotronik Inc. | 1 | $22 |
| United Therapeutics Corporation | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 5 | $18 |
| Sobi, Inc | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xience Sierra Coronary Stent$734
- Repatha$367
- Quadra Assura CRT Defibrillator$353
- Xience Sierra Coronary Stent System$347
- GORE EXCLUDER AAA Endoprosthesis$312
- AVEIR$306
- Xience Alpine cornary stent system$260
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$220
- Vascular Lithotripsy$178
- XIENCE SIERRA$155
- FFRangio System$152
- XIENCE SKYPOINT$148
- CoreValve Evolut$144
- Resolute$127
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$127
- CT Equip Undiv$123
- GORE TAG Thoracic Endoprosthesis$119
- CAMZYOS$119
- XARELTO$118
- NEXLIZET$117
How this compares
$9,624 in reported general payments places this provider in the 50th percentile of 585 interventional cardiology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ezetimibe | 32 | $514 |
| Valsartan | 12 | $443 |
| Atorvastatin Calcium | 28 | $197 |
| Metoprolol Succinate | 13 | $143 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in San Diego
- Mitul PatelSan Diego$602K
- Raghava GollapudiSan Diego$499K
- Luke OakleySan Diego$317K
- Justin CoxSan Diego$291K
- Arvin NarulaSan Diego$163K
- Matthew Pricela Jolla$2.3M
- Frederick St GoarMountain View$2.2M
- Saibal KarThousand Oaks$1.1M
- Rahul SharmaStanford$1M
- Puneet KhannaRancho Mirage$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.